Temitope O Akinmboni, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 410-328-6749 Fax: 410-328-7305 |
Dr. Antoine Kofi Fomufod, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Pediatrix Medical Group, Cheverly, MD 20785 Phone: 301-618-2630 Fax: 301-618-3941 |
Dr. Jacqueline Alissa Skelton, M.D., MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 410-328-6749 Fax: 410-328-7305 |
Dr. Sepideh Nassabeh, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 3001 Hospital Drive, Neonatal Intensive Care Unit, Prince Georges Hospital, Cheverly, MD 20785 Phone: 301-618-2000 |
Mehnur Abedin, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-3280 |
Dr. Isabelita G. Frattarola, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 3001 Hospital Dr, Cheverly, MD 20785 Phone: 301-618-3280 |
Dr. Donald Chukwuemeka Egbuonu, M.D., F.A.A.P. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Hospital Dr, Mt Washington Peds Hospital, 6th Floor Pghc, Cheverly, MD 20785 Phone: 301-618-3864 Fax: 301-772-3166 |
Dr. Rita U Onyewuenyi, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6001 Landover Rd, Suite 5, Cheverly, MD 20785 Phone: 301-772-1212 Fax: 301-772-0033 |
Dr. Amber Gilchrist, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6001 Landover Rd, Suite 5, Cheverly, MD 20785 Phone: 301-772-1212 Fax: 301-772-0033 |
Dr. Modupe Odunuga, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6122 Landover Rd, Cheverly, MD 20785 Phone: 301-322-2411 Fax: 301-322-2412 |
News Archive
Researchers compared the effects of three bone growth factors to bone morphogenetic protein 2 (BMP2) - the most commonly used agent for repair of large bone defects, which is not without risks at the doses required-and showed significant bone-healing effects including the formation of new blood vessels at low doses relative to BMP2.
Omeros Corporation today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate clinical trials evaluating OMS824, the Company's lead compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders.
A team of Princeton scientists has discovered a key mechanism in how bacteria communicate with each other, a pivotal breakthrough that could lead to treatments for cholera and other bacterial diseases.
Treatments for childhood cancer are often intense and carry the risk of lifelong health problems for survivors. An analysis of 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS), funded by the National Institutes of Health, found that the rate of severe health problems occurring five or more years after diagnosis has declined over time.
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that eating a junk-food diet during pregnancy changes the development of the opioid signalling pathway in the baby's brain and permanently alters the way this system operates after birth.
› Verified 8 days ago